Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.
about
Pharmacogenomics discovery and implementation in genome-wide association studies eraPrognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association studyThe study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLCPolymorphisms in SLCO1B3 and NR1I2 as genetic determinants of hematotoxicity of carboplatin and paclitaxel combination.Learning from biomedical linked data to suggest valid pharmacogenes.Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancerGenetic architecture of cancer and other complex diseases: lessons learned and future directions.A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersImplications of genome-wide association studies in cancer therapeuticsGermline prognostic markers for urinary bladder cancer: obstacles and opportunities.Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.Germline pharmacogenetics of paclitaxel for cancer treatment.Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.Germline Genetic Variants and Lung Cancer Survival in African Americans.Next generation modeling in GWAS: comparing different genetic architectures.The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment.Genome-wide association study of survival in early-stage non-small cell lung cancer.
P2860
Q27001573-16CE9AAE-079F-4D68-A582-1AF8F392598EQ28943366-7971B81D-048F-46B5-A7D5-B13EE58E1C8FQ30381884-9162726E-4963-4FCF-B3E5-9E4B0C9FF3F9Q33425137-9439AF17-E623-4C60-83DF-BF791ECDB3A7Q33587530-32112880-1446-459E-B90B-D0AC797035B8Q34050097-498E1C34-1BF1-4AC8-AD8C-4A3B562E21E6Q35117258-3415E2B6-589C-41A3-B708-FCF4C17BE2D9Q36693953-DB69418C-3D2C-45F3-93D4-F32C4292A421Q36698880-63628DFF-314C-460C-84C5-A6D4706209A6Q37037246-9876BF28-002A-4578-812B-8B7C3B716C57Q37161892-D2859414-9615-40F3-86FC-C0A67CCE1B29Q37298808-2353858E-DBAD-4461-9326-69BD74BB276FQ37946958-98875BBF-B998-41A6-9F3F-17E4B820466AQ38120289-0E14AB43-3A15-4F63-83C6-3A6092863F42Q38513661-0EB3BBB5-8AD4-4FE6-85B3-BF49BB152421Q40158003-B53E530D-F600-4AED-903B-6CD3FBB4226DQ42666413-0C652511-A56B-4387-8271-AE62B375B58AQ47215309-BCAFEFCC-F360-4ED8-B7B8-6EDD75103B89Q54328015-8AABFB99-D636-4915-8557-0485CE2C0953
P2860
Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Genome-wide association study ...... th carboplatin and paclitaxel.
@en
Genome-wide association study ...... th carboplatin and paclitaxel.
@nl
type
label
Genome-wide association study ...... th carboplatin and paclitaxel.
@en
Genome-wide association study ...... th carboplatin and paclitaxel.
@nl
prefLabel
Genome-wide association study ...... th carboplatin and paclitaxel.
@en
Genome-wide association study ...... th carboplatin and paclitaxel.
@nl
P2093
P1476
Genome-wide association study ...... th carboplatin and paclitaxel.
@en
P2093
Hideo Kunitoh
Hiromi Sakamoto
Hironobu Minami
Jun-Ichi Sawada
Nagahiro Saijo
Noboru Yamamoto
Noriko Katori
Sumiko Ohnami
Teruhiko Yoshida
Tomohide Tamura
P304
P356
10.1097/JTO.0B013E318200F415
P50
P577
2011-01-01T00:00:00Z